Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 101 - 150 av 205 resultater
Tid
Selskap
Tittel
Sektor
Kategori
04 Apr 2023
18:00 CEST
MAAT PHARMA
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
20103010 Biotechnology
New
04 Apr 2023
18:00 CEST
MAAT PHARMA
MaaT Pharma: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
New
30 Mar 2023
18:00 CEST
MAAT PHARMA
MaaT Pharma Announces 2022 Annual Results and Provides a Business Overview
20103010 Biotechnology
New
30 Mar 2023
18:00 CEST
MAAT PHARMA
MaaT Pharma publie ses résultats annuels pour l’année 2022 et fait un point sur ses activités
20103010 Biotechnology
New
27 Mar 2023
18:00 CEST
MAAT PHARMA
MaaT Pharma Receives Two Clinical Trial Application Authorizations to Evaluate MaaT033 in Two Therapeutic Indications in Europe
20103010 Biotechnology
New
27 Mar 2023
18:00 CEST
MAAT PHARMA
MaaT Pharma reçoit deux autorisations réglementaires pour ses deux demandes d’essais cliniques en Europe afin d’évaluer MaaT033 dans deux indications thérapeutiques
20103010 Biotechnology
New
02 Mar 2023
18:00 CET
MAAT PHARMA
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
New
02 Mar 2023
18:00 CET
MAAT PHARMA
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
20103010 Biotechnology
New
17 Feb 2023
07:30 CET
MAAT PHARMA
MaaT Pharma réalise une augmentation de capital d’environ 12,7 millions d’euros avec le soutien de ses actionnaires principaux
20103010 Biotechnology
Other financial transaction
17 Feb 2023
07:30 CET
MAAT PHARMA
MaaT Pharma Completes a Capital Increase of approximately €12.7 Million with the Support of Current Shareholders
20103010 Biotechnology
Other financial transaction
06 Feb 2023
18:00 CET
MAAT PHARMA
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
New
06 Feb 2023
18:00 CET
MAAT PHARMA
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
20103010 Biotechnology
New
03 Feb 2023
07:30 CET
MAAT PHARMA
MaaT Pharma reçoit une réponse de la FDA indiquant les étapes à suivre pour la demande d’autorisation d’essai clinique (« IND ») déposée pour MaaT013 chez les patients atteints de la maladie aiguë du greffon contre l’hôte et publie sa position de...
20103010 Biotechnology
New
03 Feb 2023
07:30 CET
MAAT PHARMA
MaaT Pharma Receives U.S. FDA Response Outlining Path Forward for Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease and Reports Cash and Revenues for Fourth Quarter 2022
20103010 Biotechnology
New
27 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma Announces Initiation of Coverage of its Stock by Kepler Cheuvreux
20103010 Biotechnology
New
27 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma annonce l’initiation de la couverture de son titre par Kepler Cheuvreux
20103010 Biotechnology
New
24 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma Provides Corporate Update and Highlights Key Expected Milestones in 2023
-
New
24 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma fait le point sur son état d’avancement et annonce les étapes clés attendues pour 2023
-
New
09 Jan 2023
22:03 CET
MAAT PHARMA
CORRECTING and REPLACING: MaaT Pharma: Half-year Report on Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
20103010 Biotechnology
New
09 Jan 2023
22:03 CET
MAAT PHARMA
CORRIGE ET REMPLACE : MaaT Pharma : Bilan semestriel du contrat de liquidité contracté avec la société de bourse Kepler Cheuvreux
20103010 Biotechnology
New
09 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma: Half-year Report on Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
20103010 Biotechnology
New
09 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma : Bilan semestriel du contrat de liquidité contracté avec la société de bourse Kepler Cheuvreux
20103010 Biotechnology
New
06 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
New
06 Jan 2023
18:00 CET
MAAT PHARMA
MaaT Pharma : Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
20103010 Biotechnology
New
11 Dec 2022
16:00 CET
MAAT PHARMA
MaaT Pharma présente les résultats complets prometteurs pour MaaT033, issus de l'étude de phase Ib à l’occasion de la 64e rencontre annuelle de l’ASH
20103010 Biotechnology
Meetings / events
11 Dec 2022
16:00 CET
MAAT PHARMA
MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting
20103010 Biotechnology
Meetings / events
10 Dec 2022
17:30 CET
MAAT PHARMA
MaaT Pharma présente des données cliniques consolidées prometteuses concernant MaaT013, à l’occasion de la 64e rencontre annuelle de l’ASH
20103010 Biotechnology
Meetings / events
10 Dec 2022
17:30 CET
MAAT PHARMA
MaaT Pharma Presents Compelling Consolidated MaaT013 Clinical Data at the 64th ASH Annual Meeting
20103010 Biotechnology
Meetings / events
29 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma organise un webcast investisseurs en marge de la conférence ASH 2022
20103010 Biotechnology
Meetings / events
29 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma To Webcast Investor Meeting in Conjunction with ASH 2022 Conference
20103010 Biotechnology
Meetings / events
08 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma Reports Cash and Revenues for Third Quarter 2022
20103010 Biotechnology
New
08 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma publie sa position de trésorerie et son chiffre d’affaires pour le troisième trimestre 2022
20103010 Biotechnology
New
07 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma Announces Participation in Scientific and Investor Conferences in November
20103010 Biotechnology
Meetings / events
07 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma annonce sa participation à plusieurs conférences scientifiques et investisseurs en novembre
20103010 Biotechnology
Meetings / events
03 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting
20103010 Biotechnology
New
03 Nov 2022
18:00 CET
MAAT PHARMA
MaaT Pharma annonce une présentation orale et un poster lors de la 64ème Rencontre annuelle de l’American Society of Hematology (ASH)
20103010 Biotechnology
New
07 Oct 2022
18:00 CEST
MAAT PHARMA
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
20103010 Biotechnology
New
07 Oct 2022
18:00 CEST
MAAT PHARMA
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
New
04 Oct 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma annonce la nomination de Nathalie Corvaïa au poste de Directrice Scientifique et renforce ses activités R&D en immuno-oncologie
20103010 Biotechnology
New
04 Oct 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma Appoints Nathalie Corvaïa as Chief Scientific Officer and Strengthens its R&D Activities in Immuno-Oncology
20103010 Biotechnology
New
29 Sep 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma publie ses résultats semestriels et réalise un point sur ses activités
20103010 Biotechnology
New
29 Sep 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma Publishes its Half Year Results and Provides a Business Overview
20103010 Biotechnology
New
08 Sep 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma annonce sa participation à trois conférences investisseurs en septembre
20103010 Biotechnology
Meetings / events
08 Sep 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September
20103010 Biotechnology
Meetings / events
06 Sep 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
New
06 Sep 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
20103010 Biotechnology
New
10 Aug 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma Announces Update on U.S. FDA Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease
20103010 Biotechnology
New
10 Aug 2022
18:00 CEST
MAAT PHARMA
MaaT Pharma annonce une mise à jour concernant la demande d’autorisation d’essai clinique déposée auprès de la FDA pour MaaT013 chez les patients atteints de la maladie aiguë du greffon contre l’hôte
20103010 Biotechnology
New
01 Aug 2022
18:00 CEST
MAAT PHARMA
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
20103010 Biotechnology
Other subject
01 Aug 2022
18:00 CEST
MAAT PHARMA
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
2
3
4
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva